Collegium to Participate in 23rd Annual Needham Virtual Healthcare ConferenceGlobe Newswire • 26 days ago
STOUGHTON, Mass., April 03, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of...
Share to Feed
This is a signal that COLL's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
This is a signal that COLL's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
In recent trading, shares of Collegium Pharmaceutical Inc (COLL) have crossed above the average analyst 12-month target price of 40.00, changing hands for 40.16/share. When a stock reaches...
This is a signal that COLL's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...
This is a signal that COLL's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
This price move could be a signal that COLL may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...
This is a signal that COLL's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
COLL's total volume now sits at 2M. The +2.79% price change was insignificant, leaving IBM's price at $39.09...
This is a signal that COLL's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...